AtriCure Reports Second Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AtriCure (ATRC) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 EPS Guidance
July 23, 2026 4:15 PM EDTAtriCure (NASDAQ: ATRC) reported Q2 EPS of $0.18, $0.19 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $153.6 million versus the consensus estimate of $151.84 million.
GUIDANCE:
AtriCure sees FY2026 EPS of $0.24-$0.32, versus the consensus of $0.12.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
... More